A new study found treating a SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours.
Researchers in the Institute for Biomedical Sciences at Georgia State University, led by Dr. Richard Plemper, Distinguished University Professor at Georgia State, originally discovered that the drug is potent against influenza viruses.
Oral Antiviral Successfully Blocks SARS-CoV-2 Transmission
Once Hospitalized, Black COVID-19 Patients Have Lower Risk of Death
Multiple research studies have shown that Black and Hispanic patients are more likely to receive a positive test result for COVID-19. However, a team of investigators at NYU Langone Health has found that once hospitalized, black patients were less likely to have a severe illness, die, or be discharged to hospice compared with white patients.